Unique ID issued by UMIN | UMIN000042427 |
---|---|
Receipt number | R000048438 |
Scientific Title | A Study on skin improving effects of a pseudo-ceramide containing formulation for sensitive skin |
Date of disclosure of the study information | 2020/11/16 |
Last modified on | 2020/11/12 15:29:25 |
Evaluation of a pseudo-ceramide containing formulation
Evaluation of a pseudo-ceramide containing formulation
A Study on skin improving effects of a pseudo-ceramide containing formulation for sensitive skin
Evaluation of a pseudo-ceramide containing formulation
Japan |
Healthy adults
Dermatology | Adult |
Others
NO
To confirm the efficacy of a pseudo-ceramide formulation on the skin of healthy females
Safety,Efficacy
Evaluation of transepidermal water loss, stratum corneum water content and dermatological assessment after treatments for 1 or 2 weeks.
Evaluation of the skin surface images, questionnaire survey and VAS after treatments for 1 or 2 weeks.
Interventional
Parallel
Randomized
Individual
Open -but assessor(s) are blinded
Active
2
Treatment
Other |
Apply the water based model lotion and the model emulsion on facial skin twice a day for a week.
After that, apply the pseudo-ceramide containing formulation in addition to above model lotions and emulsion once a day for 2 weeks.
Apply the water based model lotion and the model emulsion on facial skin twice a day for three weeks.
20 | years-old | <= |
59 | years-old | >= |
Female
1. Females who are 20-59 years old
2. Subjects who have sensitive skin consciousness.
3. Subjects who have dry skin consciousness.
4. Subjects who apply to one or more following questions.
a. I need to use skin care products twice a day on my face.
b. Cosmetics and medicines have caused redness, drying and irritation to my skin.
c. I use cosmetic products for sensitive skin.
5. Subjects who use face wash at least 5 days a week
6. Subjects who use lotion or all-in-one cosmetics at least 5 days a week
1. Subjects who are pregnancy, lactation, or subjects who may become pregnant very soon.
2. Subjects with serious underlying diseases.
3. Subjects who have clear skin symptoms at the test site.
4. Subjects who are currently undergoing hospital treatment with atopic dermatitis
5. Subjects who have had atopic dermatitis symptoms in their face within the present or past year
6. Subjects who are currently treating the skin of the face
7. Subjects who are currently using external drugs (prescription drugs, over-the-counter drugs) on the skin of the face
8. Subjects who are currently participating in product monitor surveys involving testing of the use of other drugs or with the use of quasi-drugs, cosmetics, and facial devices
9. Subjects who are determined to be not appropriate by investigator.
55
1st name | Kazuhiro |
Middle name | |
Last name | Kaizu |
Kao Corporation
R&D Skin Care Products Research
250-0002
5-3-28, Kotobukicho, Odawara, Kanagawa, 250-0002, Japan
0465-34-0559
kaizu.kazuhiro@kao.com
1st name | Seri |
Middle name | |
Last name | Akiyama |
Kao Corporation
R&D Skin Care Products Research
250-0002
5-3-28, Kotobukicho, Odawara, Kanagawa, 250-0002, Japan
0465-34-0559
akiyama.seri@kao.com
Kao Corporation
Kao Corporation
Profit organization
Human Research Ethics Committee, Kao Corporation
2-1-3 Bunka, Sumida-ku, Tokyo 131-8501, JAPAN
+81-3-5630-7263
morisaki.naoko@kao.com
NO
株式会社セブンオーワンリサーチ(東京都)
2020 | Year | 11 | Month | 16 | Day |
Unpublished
55
No longer recruiting
2020 | Year | 09 | Month | 24 | Day |
2020 | Year | 09 | Month | 24 | Day |
2020 | Year | 11 | Month | 04 | Day |
2020 | Year | 12 | Month | 31 | Day |
2020 | Year | 11 | Month | 12 | Day |
2020 | Year | 11 | Month | 12 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048438